Basel, Matthew T <br/><br/>
A cell-delivered and cell-activated SN38-dextran prodrug increases survival in a murine disseminated pancreatic cancer model.  [electronic resource] 

 -  Small (Weinheim an der Bergstrasse, Germany)  Mar 2012 
 - 913-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1613-6829 
<br/><br/><label>Standard No.: </label>10.1002/smll.201101879  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Camptothecin--administration & dosage<br/>Dextrans--administration & dosage<br/>Disease Models, Animal<br/>Irinotecan<br/>Mice<br/>Pancreatic Neoplasms--pathology<br/>Prodrugs--administration & dosage<br/>Rabbits